Updates on the Thai AIDS vaccine trial
AVAC's special Thai trial page includes background on the trial, information about the initial results, press releases, and select media coverage. Coverage of the results include:
- FAQ
document on understanding the Thai trial
results - AVAC has prepared some brief
questions and answers for advocates to explain
what the findings published and presented this
week add to the data previously presented on
September 24th
- ALVAC and AIDSVAX to Prevent HIV-1 Infection in Thailand, the peer-reviewed Thai trial results published in the New England Journal of Medicine
- HIV Vaccine Trial Results — An Opening for Further Research, an editorial response by Raphael Dolin also in NEJM
- AVAC’s report, Anticipating the Results of the Phase III AIDS Vaccine Trial in Thailand, was released in September 2009, and will be updated in the coming weeks with additional information about the plans for further data analysis, community involvement, lessons learned and questions raised by this important trial
- Additional coverage of the trial is included in the newest edition of Px Wire
- An
AIDS Vaccine is Now More than a Dream, an
article by AVAC’s executive director posted
on the Huffington
Post
- This annual gathering of researchers, funders, and advocates to discuss the state of the field, new research discoveries, and priorities for the year ahead is being held in Paris, October 19-22. Information on this year's conference and a pre-conference satellite symposium are available here.
Advocates' Call to Prepare for Results from the MDP 301 Microbicide Study
Px Wire: Thai vaccine trial commemorative edition